Publications by authors named "Gloria Guariglia"
Tips and tricks for the management of contraceptive etonogestrel implant in clinical practice: an Expert Opinion.
Eur J Contracept Reprod Health Care
December 2024
Article Synopsis
- The global use of long-acting reversible contraceptives (LARCs) is rising because they more effectively prevent unintended pregnancies compared to short-acting methods, especially in teens.
- LARCs include options like intrauterine devices and subcutaneous implants, with specialized training required for their application.
- This Expert Opinion focuses on the etonogestrel (ENG)-releasing implant, offering updated guidance on insertion, removal, and managing unscheduled bleeding based on extensive clinical experience.
Article Synopsis
- The study looks at stillbirths (when a baby dies before or during birth) happening in the last weeks of pregnancy to find out why they happen and how to improve care for pregnant women.
- Researchers analyzed data from pregnant women between 2014 and 2021 in a specific area, comparing stillbirth rates to live births and deaths before labor.
- They found that common risk factors for stillbirths during labor include having a small baby, low education levels, and being overweight before pregnancy. To help prevent these stillbirths, it's important to manage weight gain during pregnancy and have proper care before pregnancy.
Background: Stillbirth at term has great emotional impact on both parents and professionals. In developed countries, efforts to identify risk factors are mandatory to plan area-specific prevention strategies.
Objective: The aim of the study was to identify independent risk factors that contribute to stillbirth at 37 weeks' gestation or later.
The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review.
Eur J Contracept Reprod Health Care
June 2023
Introduction: Both Food and Drugs Administration and European Medicine Agency (EMA) approve the use of a triphasic combined oral contraceptive (COC) containing ethinyl-oestradiol (EE) and norgestimate (NGM) for acne vulgaris treatment in women requiring an effective contraception. COCs can target sebum production and may also play a role in decreasing follicular hyperkeratinisation.
Results: Specific advantages of the use of an anti-androgenic progestin such as NGM in this condition are presented in this review, including the lowest venous thrombosis risk in the COCs scenario, as established by the EMA, associated with a very satisfactory cycle control.